Literature DB >> 26295823

GSTP1 Polymorphisms and their Association with Glutathione Transferase and Peroxidase Activities in Patients with Motor Neuron Disease.

Beata Gajewska, Beata Kaźmierczak, Magdalena Kuźma-Kozakiewicz, Zygmunt Jamrozik, Anna Barańczyk-Kuźma1.   

Abstract

Glutathione S-transferase pi (GSTP1) is a crucial enzyme in detoxification of electrophilic compounds and organic peroxides. Together with Se-dependent glutathione peroxidase (Se-GSHPx) it protects cells against oxidative stress which may be a primary factor implicated in motor neuron disease (MND) pathogenesis. We investigated GSTP1 polymorphisms and their relationship with GST and Se-GSTPx activities in a cohort of Polish patients with MND. Results were correlated with clinical phenotypes. The frequency of genetic variants for GSTP1 exon 5 (I105V) and exon 6 (A114V) was studied in 104 patients and 100 healthy controls using real-time polymerase chain reaction. GST transferase activity was determined in serum with 1-chloro-2,4-dinitrobenzene, its peroxidase activity with cumene hydroperoxide, and Se-GSHPx activity with hydrogen peroxide. There were no differences in the prevalence of GSTP1 polymorphism I105V and A114V between MND and controls, however the occurrence of CT variant in codon 114 was associated with a higher risk for MND. GSTP1 polymorphisms were less frequent in classic ALS than in progressive bulbar palsy. In classic ALS C* (heterozygous I /V and A /V) all studied activities were significantly lower than in classic ALS A* (homozygous I /I and A/A). GST peroxidase activity and Se-GSHPx activity were lower in classic ALS C* than in control C*, but in classic ALS A* Se-GSHPx activity was significantly higher than in control A*. It can be concluded that the presence of GSTP1 A114V but not I105V variant increases the risk of MND, and combined GSTP1 polymorphisms in codon 105 and 114 may result in lower protection of MND patients against the toxicity of electrophilic compounds, organic and inorganic hydroperoxides.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26295823     DOI: 10.2174/1871527314666150821104019

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  5 in total

1.  Influence of GSTP1 rs1695 polymorphism on survival in male patients' amyotrophic lateral sclerosis: a genetic association study in Brazilian population.

Authors:  Rodrigo da Silva Santos; Angela Adamski da Silva Reis; Jéssica Barletto de Sousa Barros; Kamilla de Faria Santos; Dhiogo da Cruz Pereira Bento; Leandro do Prado Assunção
Journal:  Mol Biol Rep       Date:  2021-10-08       Impact factor: 2.316

2.  Validation of qPCR reference genes in lymphocytes from patients with amyotrophic lateral sclerosis.

Authors:  Ewa Usarek; Anna Barańczyk-Kuźma; Beata Kaźmierczak; Beata Gajewska; Magdalena Kuźma-Kozakiewicz
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

3.  No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population.

Authors:  Jéssica Barletto de Sousa Barros; Kamilla de Faria Santos; Rômulo Morais Azevedo; Rayana Pereira Dantas de Oliveira; Ana Carolina Dourado Leobas; Dhiogo da Cruz Pereira Bento; Rodrigo da Silva Santos; Angela Adamski da Silva Reis
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240

Review 4.  The Association between Gene-Environment Interactions and Diseases Involving the Human GST Superfamily with SNP Variants.

Authors:  Antoinesha L Hollman; Paul B Tchounwou; Hung-Chung Huang
Journal:  Int J Environ Res Public Health       Date:  2016-03-29       Impact factor: 3.390

5.  Glutathione S-transferase Omega 2 DD genotype is associated with an increased risk of sporadic amyotrophic lateral sclerosis in Chinese men.

Authors:  Zhiliang Fan; Hong Jiang; Xueqin Song; Yansu Guo; Xinying Tian
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.